Serial measurements of serum thyroglobulin in response to recombinant human thyrotropin stimulation.
作者信息
Weiss Richard, Magner James
机构信息
Medical Affairs, Genzyme Corporation, a Sanofi company, Cambridge, Massachusetts.
出版信息
Thyroid. 2015 Jun;25(6):708-10. doi: 10.1089/thy.2014.0586. Epub 2015 Apr 29.
Abstract
摘要
相似文献
1
Serial measurements of serum thyroglobulin in response to recombinant human thyrotropin stimulation.在重组人促甲状腺素刺激下血清甲状腺球蛋白的系列测量。
Thyroid. 2015 Jun;25(6):708-10. doi: 10.1089/thy.2014.0586. Epub 2015 Apr 29.
2
Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement.通过血清甲状腺球蛋白测量检测残留和复发性分化型甲状腺癌。
Thyroid. 1999 May;9(5):435-41. doi: 10.1089/thy.1999.9.435.
3
Undetectable serum thyroglobulin levels in patients with medullary thyroid carcinoma after total thyroidectomy without radioiodine ablation.甲状腺髓样癌患者全甲状腺切除术后未行放射性碘消融时血清甲状腺球蛋白水平不可检测。
Thyroid. 2012 Jul;22(7):680-2. doi: 10.1089/thy.2011.0508. Epub 2012 Jun 4.
4
[Assay of thyroglobulin in the study of patients with differentiated thyroid carcinoma].
Acta Med Port. 1984 Mar;5(3):73-8.
5
The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.在全甲状腺切除和放射性碘消融治疗后甲状腺癌分化型患者中，抗甲状腺球蛋白抗体阳性且甲状腺功能正常的患者随访期间血清促甲状腺激素升高时，诊断性全身扫描和血清甲状腺球蛋白的价值。
Thyroid. 2012 Feb;22(2):113-6. doi: 10.1089/thy.2011.0020. Epub 2012 Jan 6.
6
Is serum thyroglobulin a useful marker for thyroid cancer in patients who have not had ablation of residual thyroid tissue?
Thyroid. 1997 Jun;7(3):343-6. doi: 10.1089/thy.1997.7.343.
7
Discordant serum thyroglobulin results generated by two classes of assay in patients with thyroid carcinoma: correlation with clinical outcome after 3 years of follow-up.两类检测方法在甲状腺癌患者中产生的血清甲状腺球蛋白结果不一致：与3年随访后的临床结局的相关性
Cancer. 2003 Jul 1;98(1):41-7. doi: 10.1002/cncr.11472.
8
Stimulated thyroglobulin at recombinant human TSH-aided ablation predicts disease-free status one year later.rhTSH 辅助消融治疗后刺激甲状腺球蛋白可预测一年后无病状态。
J Clin Endocrinol Metab. 2013 Nov;98(11):4364-72. doi: 10.1210/jc.2013-2267. Epub 2013 Sep 13.
9
Serum thyroglobulin measurements in differentiated thyroid cancer.分化型甲状腺癌的血清甲状腺球蛋白检测
Biomed Pharmacother. 2000 Jul;54(6):330-3. doi: 10.1016/S0753-3322(00)80058-X.
引用本文的文献
1
Change of Therapeutic Response Classification According to Recombinant Human Thyrotropin-Stimulated Thyroglobulin Measured at Different Time Points in Papillary Thyroid Carcinoma.根据重组人促甲状腺素刺激的甲状腺球蛋白在不同时间点测量结果对甲状腺乳头状癌治疗反应分类的变化
Nucl Med Mol Imaging. 2021 Jun;55(3):116-122. doi: 10.1007/s13139-021-00699-2. Epub 2021 Apr 29.
2
Optimization of serum thyroglobulin measured at different time points for prognostic evaluation in differentiated thyroid carcinoma patients.分化型甲状腺癌患者不同时间点血清甲状腺球蛋白测定用于预后评估的优化
Medicine (Baltimore). 2020 Apr;99(14):e19652. doi: 10.1097/MD.0000000000019652.
3
Comparison of day 3 and day 5 thyroglobulin results after thyrogen injection in differentiated thyroid cancer patients.分化型甲状腺癌患者注射促甲状腺素后第3天和第5天甲状腺球蛋白结果的比较。
Ther Adv Endocrinol Metab. 2018 Jun;9(6):177-183. doi: 10.1177/2042018818770108. Epub 2018 Apr 17.
4
Recombinant human TSH stimulated thyroglobulin levels at remnant ablation predict structural incomplete response to treatment in patients with differentiated thyroid cancer.重组人促甲状腺素刺激下的残余灶消融时甲状腺球蛋白水平可预测分化型甲状腺癌患者治疗的结构不完全缓解。
Medicine (Baltimore). 2017 Jul;96(29):e7512. doi: 10.1097/MD.0000000000007512.
5
Early stimulated thyroglobulin for response prediction after recombinant human thyrotropin-aided radioiodine therapy.重组人促甲状腺素辅助放射性碘治疗后早期刺激甲状腺球蛋白用于反应预测
Ann Nucl Med. 2017 Oct;31(8):616-622. doi: 10.1007/s12149-017-1190-3. Epub 2017 Jul 7.
本文引用的文献
1
Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paper.用高敏感分析法检测分化型甲状腺癌患者的甲状腺球蛋白：临床立场文件。
Eur J Endocrinol. 2014 Aug;171(2):R33-46. doi: 10.1530/EJE-14-0148. Epub 2014 Apr 17.
2
Does an undetectable rhTSH-stimulated Tg level 12 months after initial treatment of thyroid cancer indicate remission?初始治疗甲状腺癌 12 个月后，促甲状腺激素（rhTSH）刺激后的甲状腺球蛋白水平不可检测是否意味着缓解？
Clin Endocrinol (Oxf). 2011 Jan;74(1):111-7. doi: 10.1111/j.1365-2265.2010.03898.x.
3
Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system.评估全甲状腺切除术和放射性碘残留消融后分化型甲状腺癌的复发风险：使用治疗反应变量来修正新的美国甲状腺协会分期系统预测的初始风险估计。
Thyroid. 2010 Dec;20(12):1341-9. doi: 10.1089/thy.2010.0178. Epub 2010 Oct 29.
4
A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer.重组人促甲状腺素与甲状腺激素撤减用于检测甲状腺残留组织或癌症的比较。
J Clin Endocrinol Metab. 1999 Nov;84(11):3877-85. doi: 10.1210/jcem.84.11.6094.
Zotero 插件